Abstract:Aging HSCs display a progressive and growth-factor sensitive elongation of G 1 . Increased growth-factor concentrations are required to stimulate mitogenesis in aging HSCs associated with reduced AKT activation. Human hematopoietic stem cells (HSCs), like their counterparts in mice, comprise a functionally and molecularly heterogeneous population of cells throughout life that, collectively, maintain required outputs of mature blood cellsunder homeostatic conditions. An early developmental change in the HSC population in both species includes a postnatal switch from most of these cells existing in a rapidly cycling state and maintenance of a high self-renewal potential to a majority in a quiescent state with an overall reduced self-renewal potential. However, despite the well-established growth factor dependence of HSC proliferation, if and how this mechanism of HSC regulation might be affected by aging has remained poorly understood. To address this gap, we isolated highly HSC-enriched CD34+CD38-CD45RA-CD90+CD49f+ (" CD49f+ ") cells from cord blood and adult bone marrow and mobilized peripheral blood samples obtained from normal humans spanning 7 decades of age and then measured their functional and molecular responses to growth-factor stimulation in vitro and regenerative activity in vivo in transplanted mice. Initial experiments revealed advancing donor age was accompanied by a significant and progressively delayed proliferative response but not the altered mature cell outputs seen in normal older individuals. Importantly, subsequent dose-response analyses revealed an age-associated reduction in the growth-factor stimulated proliferation of CD49f+ cells mediated by reduced intrinsic activation of AKT and altered cell-cycle entry and progression. These findings identify a new intrinsic, pervasive, and progressive aging-related alteration in the biological and signaling mechanisms required to drive the proliferation of very primitive normal human hematopoietic cells.

Mtor Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

Regulation of Hematopoietic Stem Cells Differentiation, Self-Renewal, and Quiescence Through the Mtor Signaling Pathway

Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice

Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.

mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate

Age-related Noncanonical TRMT6–TRMT61A Signaling Impairs Hematopoietic Stem Cells

TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species.

mTOR and Aging: An Old Fashioned Dress

Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells

Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice

Maintenance of Hematopoietic Stem Cells Through Regulation of Wnt and Mtor Pathways

Mechanisms and rejuvenation strategies for aged hematopoietic stem cells

AMPK / TSC 2 / Mtor Pathway Regulates Replicative Senescence of Human Vascular Smooth Muscle Cells

The mTOR signaling pathway in cardiac aging

Wip1 Deficiency Impairs Haematopoietic Stem Cell Function Via P53 and Mtorc1 Pathways

Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging

mTORC2: A neglected player in aging regulation

The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs

Long‐term mid‐onset dietary restriction rejuvenates hematopoietic stem cells and improves regeneration capacity of total bone marrow from aged mice

An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state